Cargando…
Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’
BACKGROUND: We previously reported that women from high-risk families who tested negative for a BRCA1 or BRCA2 (BRCA1/2) mutation were four times more likely to develop breast cancer compared to women in the general population. Preventive measures and risk factors for breast cancer development in th...
Autores principales: | Kotsopoulos, Joanne, Metcalfe, Kelly, Alston, Jill, Nikitina, Dina, Ginsburg, Ophira, Eisen, Andrea, Demsky, Rochelle, Akbari, Mohammad, Zbuk, Kevin, Narod, Steven A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3973748/ https://www.ncbi.nlm.nih.gov/pubmed/24667084 http://dx.doi.org/10.1186/1471-2407-14-221 |
Ejemplares similares
-
Predictors of mammographic density among women with a strong family history of breast cancer
por: Moran, Olivia, et al.
Publicado: (2019) -
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012) -
Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Odén, Lovisa, et al.
Publicado: (2016) -
Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific
por: Chehade, Rania, et al.
Publicado: (2016) -
Plasma RANKL levels are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Zaman, Tasnim, et al.
Publicado: (2019)